rTMS Combined With Motor Training for the Treatment of Upper Limb Motor Dysfunction in Stroke Patients

NCT ID: NCT06752499

Last Updated: 2025-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-20

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trials is to investigate the effectiveness of online repetitive transcranial magnetic stimulation (rTMS) in enhancing upper limb motor rehabilitation during the subacute and chronic phase of stroke. It will also learn about the safety of online rTMS intervention methods. The main questions it aims to answer are:

1. Does rTMS combined with motor training improve motor rehabilitation in patients?
2. Does repetitive transcranial magnetic stimulation (rTMS) combined with motor training enhance the upper limb motor rehabilitation ability in stroke patients by strengthening the functional coupling of the motor circuit to achieve functional reorganization of the brain network ?

Researchers will compare online rTMS to offline and sham stimulation in stroke patients to see if online rTMS works to alleviate motor dysfunction in multicenter multicenter, blinded and controlled trial.

Participants will:

1. randomized to one group(online, offline or sham);
2. receive rTMS treatment for 10 days, with 5 working days per week for a total of two weeks;
3. receive magnetic resonance imaging (MRI) and electroencephalogram (EEG) evaluations before and after the entire treatment;
4. conduct scales and MEP assessment one day before the treatment, as well as one day, one month, and three months after the treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, patients were be randomly assigned to three groups: online, offline and sham groups. if patients were able to induce MEPs, intensity of TMS will be 80% RMT; if not , inensity of TMS will be 70%\~80% of TMS output.

Patients were stimulated over 2 week period, 4 sessions of tasks were performed everyday. The patient will undergo a 2-week (10-day) stimulation protocol, with fourty tasks performed daily. This includes one session of 10 baseline tasks measurement and three sessions of 5 Hz rTMS synchronized with 10 motor tasks. rTMS will be applied to the ipsilesional motor cortex.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Upper Extremity Paresis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Online stimulation

5 Hz rTMS is applied to the primary motor cortex on the affected hemisphere when the patients are performing motor tasks.

Group Type EXPERIMENTAL

Online stimulation

Intervention Type DEVICE

5 Hz rTMS is applied to the primary motor cortex on the affected hemisphere when the patients are performing motor tasks.

Offline stimulation

After 5 Hz rTMS is applied to the primary motor cortex on the affected hemisphere, the patients perform motor tasks.

Group Type ACTIVE_COMPARATOR

Offline stimulation

Intervention Type DEVICE

After 5 Hz rTMS is applied to the primary motor cortex on the affected hemisphere, the patients perform motor tasks.

Sham stimulation

Sham rTMS is applied to the primary motor cortex on the affected hemisphere when the patients are performing motor tasks.

Group Type SHAM_COMPARATOR

Sham stimulation

Intervention Type DEVICE

Sham rTMS is applied to the primary motor cortex on the affected hemisphere when the patients are performing motor tasks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online stimulation

5 Hz rTMS is applied to the primary motor cortex on the affected hemisphere when the patients are performing motor tasks.

Intervention Type DEVICE

Offline stimulation

After 5 Hz rTMS is applied to the primary motor cortex on the affected hemisphere, the patients perform motor tasks.

Intervention Type DEVICE

Sham stimulation

Sham rTMS is applied to the primary motor cortex on the affected hemisphere when the patients are performing motor tasks.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The patient is first diagnosed with stroke through neurological examination, CT or MRI scan.
2. The vital signs are stable and there is a certain degree of upper limb motor dysfunction.
3. The age is between 20 and 80 years old.
4. The cognitive ability is not significantly affected and the patient can cooperate with various examinations and assessments, with a MMSE score ≥ 20 points.
5. There are no serious complications (such as pneumonia, heart failure, urinary tract infection or malnutrition).
6. There is no pathological condition that is a contraindication for TMS in the medical history (for example, patients with metal in the brain, such as aneurysm clips, patients with a cardiac pacemaker, pregnant women, or those with a history of epileptic seizures).
7. The patient or guardian agrees to sign the informed consent form.

Exclusion Criteria

1. Patients with severe heart, lung, liver, kidney diseases and malignant tumors;
2. Those with a history of aphasia, severe cognitive impairment or mental illness;
3. Patients who have had a history of epileptic seizures in the last month or are taking anti-epileptic drugs recently;
4. Those with severe visual or hearing impairments, unable to communicate normally;
5. People with metal implants, pacemakers, skull defects or other conditions that prevent them from undergoing TMS.
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Changhai Hospital

OTHER

Sponsor Role collaborator

Shanghai Yangzhi Rehabilitation Hospital

UNKNOWN

Sponsor Role collaborator

shanghai center for brain science and brain-inspired technology

UNKNOWN

Sponsor Role collaborator

Ruijin Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qing Xie, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Ruijin Hospital, affiliated to Shanghai Jiao Tong University, School of medicine

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Yang Zhi Rehabilitation Hospital

Shanghai, Songjiang, China

Site Status RECRUITING

Changhai Hospital

Shanghai, Yangpu, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yang LIU, Master of Medicine

Role: CONTACT

+8615821650228

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yifeng WANG

Role: primary

+8602154661789

Hong Zhang

Role: primary

37730011-22625

Jiamin Li

Role: primary

021-31166666

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022361

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.